Stable cationically crosslinkable/polymerizable dental composition with a high filler content

Abstract

Stable and substantially filled cationic dental compositions are described which include: (1) at least one cationically reactive compound (A); (2) at least one dental filler (B); (3) optionally, at least one dispersant (C) composed of at least one organic polymer or copolymer; (4) at least one cationic photoinitiator (D); and (5) optionally, at least one photosensitizer (E). The dental filler (B) is treated with at least one organosilicon coupling agent (F), and at least one compound (G). The organosilicon coupling agent (F) has at least one reactive function (rfA) directly linked to a silicon atom forming after activation of a chemical bond with the dental filler, and at least one reactive function (rfB) not directly linked to a silicon atom, forming after activation, a chemical bond with a reactive function (rfC) of the compound (G).

1 . A dental composition comprising: 
 (1) at least one cationically reactive compound (A);    (2) at least one dental filler (B);    (3) optionally at least one dispersant (C) comprising at least one organic polymer or copolymer;    (4) at least one cationic photoinitiator (D);    (5) and optionally at least one photosensitizer (E),    wherein said at least one dental filler (B) is treated:    a) with at least one organosilicon coupling agent (F) and    b) with at least one compound (G),    said organosilicon coupling agent (F) comprising at least one reactive function (rfA) directly linked to a silicon atom reacting with the dental filler, and at least one reactive function (rfB) not directly linked to a silicon atom reacting with a reactive function (rfC) of the compound (G).    
   
   
       2 . The dental composition as claimed in  claim 1 , in which: 
 the reactive function (rfA) directly linked to a silicon atom of the organosilicon coupling agent (F) is an alkoxy, enoxy or hydroxyl function;    the reactive function (rfB) not directly linked to a silicon atom of the organosilicon coupling agent (F) is an oxirane, oxetane, hydroxyl, acid, carboxylic acid anhydride or diol function; and    the reactive function (rfC) of the compound (G) is an oxirane, oxetane, alkenyl ether or carbonate function.    
   
   
       3 . The dental composition as claimed in  claim 1 , in which at least one dental filler (B) is treated via a process (I) comprising the following steps: 
 a) the dental filler (B) and at least one organosilicon coupling agent (F) comprising at least one alkoxy, enoxy and/or hydroxyl function directly linked to a silicon atom and at least one oxirane, oxetane, hydroxyl, acid, carboxylic acid anhydride and/or diol function are mixed together in solvent medium,    b) the solvent is evaporated off to obtain an intermediate dental filler (B-1),    c) the intermediate dental filler (B-1) undergoes a heat treatment so as to allow the coupling reaction between the intermediate dental filler (B-1) and the coupling agent (F) and thus to obtain an intermediate dental filler (B-2),    d) the intermediate dental filler (B-2) is next mixed in solvent medium with at least one compound (G) comprising at least one oxirane, oxetane, alkenyl ether and/or carbonate function,    e) the solvent is evaporated off to obtain an intermediate dental filler (B-3), and    f) the intermediate dental filler (B-3) undergoes a heat treatment so as to allow the reaction between the intermediate dental filler (B-3) and the compound (G) and thus to obtain a treated dental filler (B-4).    
   
   
       4 . The dental composition as claimed in  claim 3 , in which the heat treatment of steps c) and f) of the process (I) is performed by heating to a temperature of less than or equal to 200° C.  
   
   
       5 . The dental composition as claimed in  claim 1 , in which the overall content of dental fillers (B) represents up to 85% by weight and relative to the total weight of the dental composition.  
   
   
       6 . The dental composition as claimed in  claim 1 , in which the treatment of the dental filler (B) is performed with up 20% by weight of the compound (G) and/or up to 20% by weight of the compound (F) relative to the total weight of the dental composition.  
   
   
       7 . The dental composition as claimed in  claim 1 , in which the organosilicon coupling agent (F) is of the formula:  
     
       
         
         
             
             
         
       
     
     in which formula: 
 R is a hydrogen or a linear or branched C 1 -C 4  alkyl radical,  
 R 1  is a linear or branched alkyl radical or a phenyl radical,  
 x is equal to 0, 1 or 2, and  
 X being defined by one of the following formulae:  
                     
 with:  
 E and D which are identical or different radicals chosen from linear or branched C 1 -C 12  alkyls,  
 z is equal to 0 or 1;  
 n is equal to 0 or 1;  
 is equal to 0, 1, 2, 3, 4, 5 or 6;  
 R 2 , R 3 , R 4 , R 5 , R 6 , R 7  and R 8  are radicals, which may be identical or different, representing a hydrogen or a linear or branched C 1 -C 12  alkyl.  
 
   
   
       8 . The dental composition as claimed in  claim 7 , in which the organosilicon coupling agent (F) is chosen from the group consisting of the following compounds: glycidyloxypropyltrimethoxysilane, the product of hydrolysis of glycidyloxypropyltrimethoxysilane; glycidyloxypropyltriethoxysilane, the product of hydrolysis in acidic medium of glycidyloxypropyltriethoxysilane; glycidyloxypropyldimethoxymethylsilane and its hydrolysis product, β-(3,4-epoxycyclohexyl)ethyltriethoxysilane and its hydrolysis product, and β-(3,4-epoxycyclohexyl)ethyltrimethoxysilane and its hydrolysis product.  
   
   
       9 . The dental composition as claimed in  claim 1 , in which the compound (G) is an organic or organosiloxane monomer, oligomer or polymer comprising at least one oxirane, oxetane, alkenyl ether and/or carbonate function.  
   
   
       10 . The dental composition as claimed in  claim 9 , in which the compound (G) comprises at least one function chosen from the group consisting of the structures (M-7) to (M-12) below:  
     
       
         
         
             
             
         
       
     
     with R″ representing a linear or branched C 1 -C 6  alkyl radical.  
   
   
       11 . The dental composition as claimed in  claim 9 , in which the compound (G) is a silicone oligomer (G-1) or a silicone polymer (G-2).  
   
   
       12 . The dental composition as claimed in  claim 11 , in which the silicone oligomer (G-1) and the silicone polymer (G-2) comprise: 
 a) at least one unit of formula:                          in which formula: 
 a=0, 1 or2,  
 R 0 , which may be identical or different, represents an alkyl, cycloalkyl, aryl, vinyl, hydrogeno or alkoxy radical,  
 Z, which may be identical or different, is an organic substituent comprising at least one oxirane, alkenyl ether, oxetane and/or carbonate function, and  
   b) at least two silicon atoms.    
   
   
       13 . The dental composition as claimed in  claim 12 , in which the silicone oligomer (G-1) and the silicone polymer (G-2) are chosen from the group consisting of the compounds of formulae:  
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       L=H; OH; Me; Phenyl; C 1 -C 12  Alkyl; C 1 -C 6  Cycloalkyl; or the following groups  
       
         
           
           
               
               
           
         
       
       with n<100; a<100 and m<100: and  
       o)  
       
         
           
           
               
               
           
         
       
       with n<100  
         (S-15)  
       in which formulae R o  or R 0 , which may be identical or different, represents an alkyl, cycloalkyl or aryl radical.  
     
   
   
       14 . The dental composition as claimed in  claim 1 , wherein the cationically reactive compound (A) is chosen from the group of monomers and/or (co)polymers selected from the group consisting of: 
 epoxys, vinyl ethers, oxetanes, spiroorthocarbonates and spiroorthoesters, and combinations thereof.    
   
   
       15 . The dental composition as claimed in  claim 14 , in which the cationically reactive compound (A) comprises at least one crosslinkable and/or polymerizable silicone oligomer (G-1) or silicone polymer (G-2), which is liquid at room temperature or thermofusible at a temperature below 100° C., and comprising: 
 a) at least one unit having the following formula:                          in which formula: 
 a=0, 1 or 2,  
 R 0 , which may be identical or different, represents an alkyl, cycloalkyl, aryl, vinyl, hydrogeno or alkoxy radical,  
 Z, which may be identical or different, is an organic substituent comprising at least one oxirane, alkenyl ether, oxetane, dioxolane and/or carbonate function, and  
   b) at least two silicon atoms.    
   
   
       16 . The dental composition as claimed in  claim 15 , wherein the unit (M-13) comprises groups Z chosen from the group consisting of the radicals (R-1) to (R-9) below:  
     
       
         
         
             
             
         
       
       with R″ representing a linear or branched C 1 -C 6  alkyl radical.  
     
   
   
       17 . The dental composition as claimed in  claim 13 , wherein the cationically reactive compound (A) is chosen from the group consisting of the compounds (S-1) to (S-15).  
   
   
       18 . The dental composition as claimed in  claim 1 , wherein the cationic photoinitiator (D) is a borate and is chosen from those of the following formula in which: 
 a) the cationic species of the borate is selected from the group consisting of:    (1) the onium salts of formula:      [(R 9 ) n -A-(R 10 ) m ] +   (I)    in which formula: 
 A represents an element from groups 15 to 17,  
 R 9  represents a C 6 -C 20  carbocyclic or heterocyclic aryl radical, said heterocyclic radical optionally containing nitrogen or sulfur as hetero elements,  
 R 10  represents R 9  or a linear or branched C 1-C   30  alkyl or alkenyl radical; said radicals R 9  and R 10  being optionally substituted with a C 1 -C 25  alkoxy, C 1 -C 25  alkyl, nitro, chloro, bromo, cyano, carboxyl, ester or mercapto group,  
 m and n are integers, with n+m=v+1, v being the valency of the element A,  
   (2) oxoisothiochromanium salts; and    (3) organometallic salts having the following formula:      (L 1 L 2 L 3 M) +q    (II)    in which formula: 
 M represents a metal from groups 4 to 10,  
 L1 represents a ligand linked to the metal M via π electrons, the ligand being chosen from the ligands η 3 -alkyl, η 5 -cyclopentadienyl and η 7 -cycloheptatrienyl and the η 6 -aromatic compounds chosen from the optionally substituted η 6 -benzene ligands and the compounds containing from 2 to 4 fused rings, each ring being capable of contributing to the valency layer of the metal M via 3 to 8 π electrons,  
 L2 represents a ligand linked to the metal M via π electrons, the ligand being chosen from the η 7 -cycloheptatrienyl ligands and the η 6 -aromatic compounds chosen from the optionally substituted η 6 -benzene ligands and the compounds containing from 2 to 4 fused rings, each ring being capable of contributing to the valency layer of the metal M via 6 or 7 π electrons,  
 L3 represents from 0 to 3 identical or different ligands linked to the metal M via σ electrons, this or these ligand(s) being chosen from CO and NO 2 +; the total electronic charge q of the complex toward which L1, L2 and L3 contribute and the ionic charge of the metal M being positive and equal to 1 or 2; and  
   b) the anionic borate species of the formula:      [BX a R b ] −   (III)    in which formula: 
 a and b are integers ranging for a from 0 to 3 and for b from 1 to 4 with a+b =4,  
 the symbols X represent: 
 a halogen atom with a=0 to 3, or  
 an OH function with a=0 to 2,  
 
 the symbols R are identical or different and represent: 
 a phenyl radical substituted with at least one electron-withdrawing group, and/or with at least 2 halogen atoms, this being the case when the cationic species is an onium of an element from groups 15 to 17,  
 a phenyl radical substituted with at least one element or an electron-withdrawing group, this being the case when the cationic species is an organometallic complex of an element from groups 4 to 10, or  
 an aryl radical containing at least two aromatic nuclei, optionally substituted with at least one element or an electron-withdrawing group, irrespective of the cationic species.  
 
   
   
   
       19 . The composition as claimed in  claim 18 , wherein the cationic photoinitiator (D) is chosen from the group consisting of the following compounds: 
 (P-16): [(C 8 H 17 )—O—C 6 H 4 —I—C 6 H 5 )] + , [B(C 6 F 5 ) 4 ] − ;    (P-17): [C 12 H 25 —C 6 H 4 —I—C 6 H 5 ] + , [B(C 6 F 5 ) 4 ] − ;    (P-18): [(C 8 H 17 —O—C 6 H 4 ) 2 ] + , [B(C 6 F 5 ) 4 ] − ;    (P-19): [(C 8 H 17 )—O—C 6 H 4 —I—C 6 H 5 )] + , [B(C 6 F 5 ) 4 ] − ;    (P-20): [(C 6 H 5 ) 2 S—C 6 H 4 —O—C 8 H 17 ] + , [B(C 6 H 4 CF 3 ) 4 ] − ;    (P-21): [(C 12 H 25 —C 6 H 4 ) 2 I] + , [B(C 6 F 5 ) 4 ] − ;    (P-22): [CH 3 —C 6 H 4 —I—C 6 H 4 —CH(CH 3 ) 2   + , [B(C 6 F 5 ) 4 ] − ;    (P-23): (η5-cyclopentadienyl)(η6-toluene)Fe + , [B(C 6 F 5 ) 4 ] − ;    (P-24): (η5-cyclopentadienyl)(η6-methyl-1-naphthalene)Fe + , [B(C 6 F 5 ) 4 ] − ;    (P-25): (η5-cyclopentadienyl)(η6-cumene)Fe + , [B(C 6 F 5 ) 4 ] − ;    (P-26): [(C 12 H 25 —C 6 H 4 ) 2 ] + , [B(C 6 H 3 (CF 3 ) 2 ] − ;    (P-27): [CH 3 —C 6 H 4 —I—C 6 H 4 —CH 2 CH(CH 3 ) 2 ] + , [B(C 6 F 5 ) 4 ] − ;    (P-28): [CH 3 —C 6 H 4 )—I—C 6 H 4 —CH 2 CH(CH 3 ) 2 ] + , [B(C 6 H 3 (CF 3 ) 2 ) 4 ] − ; and    (P-29): [CH 3 —C 6 H 4 —I—C 6 H 4 —CH(CH 3 ) 2 ] + , [B(C 6 H 3 (CF 3 ) 2 ) 4 ] − .    
   
   
       20 . The dental composition as claimed in  claim 1 , wherein the cationic photoinitiator (D) is an iodonium salt.  
   
   
       21 . The dental composition as claimed in  claim 1 , in which the photosensitizer (E) comprises in its structure one or more substituted or unsubstituted aromatic nuclei having a residual light absorption of between 200 and 500 nm.  
   
   
       22 . The dental composition as claimed in  claim 21 , in which the photosensitizer (E) is chosen from the group consisting of compounds of the anthracene, thioxanthone, camphorquinone and phenanthrenequinone class, and also mixtures thereof.  
   
   
       23 . The dental composition as claimed in  claim 22 , in which the photosensitizer (E) is a salt of a thioxanthone substituted with at least one group comprising an ammonium function.  
   
   
       24 . The dental composition as claimed in  claim 23 , wherein the associated anion of the salt of the thioxanthone substituted with at least one group comprising an ammonium function is chosen from the following anions: a halide, BF 4   − , PF 6   − ; SbF 6   − ; the anion (III) of formula [BX a R b ] −  defined as claimed in  claim 18 , R f SO 3   − ; (R f SO 2 ) 3 C −  or (R f SO 2 ) 2 N −  with R f  being a linear or branched alkyl radical substituted with at least one halogen atom.  
   
   
       25 . The dental composition as claimed in  claim 1 , in which the photosensitizer (E), optionally in combination with at least one camphorquinone, a phenanthrenequinone and/or a substituted anthracene, has the formula:  
     
       
         
         
             
             
         
       
     
     in which formula: 
 R 22  and R 23  are identical or different and represent a hydrogen or an optionally substituted C 1 -C 10  alkyl radical, (X − ) being an anionic species, the anion (III) of formula [BX a R b ] −  defined as claimed in  claim 16 , R f SO 3   − ; (R f SO 2 ) 3 C −  or (R f SO 2 ) 2 N − , with R f  being a linear or branched alkyl radical substituted with at least one halogen atom,  
 
   
   
       26 . The dental composition as claimed in  claim 1 , in which the photosensitizer (E), optionally in combination with at least one camphorquinone, a phenanthrenequinone and/or a substituted anthracene, has the formula:  
     
       
         
         
             
             
         
       
     
   
   
       27 . The dental composition as claimed in  claim 1 , in which the photosensitizer (E) is chosen from the group consisting of the following compounds: 
 (PS-30): 3-(3,4-dimethyl-9-oxo-9-thioxanthenen-2-yloxy)-2-hydroxypropyl)trimethylammonium chloride;    (PS-31): 3-(3,4-dimethyl-9-oxo-9-thioxanthenen-2-yloxy)-2-hydroxypropyl)trimethylammonium tetrakis(pentafluorophenyl)borate;    (PS-32): 3-(3,4-dimethyl-9-oxo-9-thioxanthenen-2-yloxy)-2-hydroxypropyl)trimethylammonium tetrakis(bis(trifluoromethyl)phenyl)borate;    (PS-33): phenanthrenequinone;    (PS-34): camphorquinone;    (PS-35): acenaphthenequinone;    (PS-36): dibenzoyl peroxide;    (PS-37): 2-ethyl-9,10-dimethoxyanthracene;    (PS-38): 9,10-diethoxyanthracene;    (PS-39): 9,10-dibutoxyanthracene;    (PS-40): 9-hydroxymethylanthracene;    (PS-41): 2-dimethylaminothioxanthone;    (PS-42): 3-ethylcarboxy-7-methoxythioxanthone;    (PS-43): 1-phenylthio-4-propoxythioxanthone;    (PS-44): 2-methoxythioxanthone;    (PS-45): 2-(N,N-diethylaminopropoxy)thioxanthone;    (PS-46): 2-isopropylthioxanthone;    (PS-47): 1-chloro-4-propoxythioxanthone;    (PS-48): 4-isopropylthioxanthone;                          and mixtures thereof.    
   
   
       28 . The dental composition as claimed in  claim 1 , in which the photosensitizer (E) is chosen from the group consisting of the compounds of the coumarin, diketone, fluorone, amino ketone and para-aminostyryl ketone family, and also mixtures thereof.  
   
   
       29 . The dental composition as claimed in  claim 11 , in which the silicone polymer (G-2) or the silicone oligomer (G-1) is combined with an organic epoxy or oxetane resin of formula (S-103) or (S-104):  
     
       
         
         
             
             
         
       
     
     with: 
 0≦n≦100 and  
 D=radical chosen from linear or branched C 1 -C 12  alkyls.  
 
   
   
       30 . The dental composition as claimed in  claim 1 , in which the dental filler (B) is a mineral glass or a combustion silica.  
   
   
       31 . The dental composition as claimed in  claim 1 , in which the compound (G) is a silane (G-3) of formula:  
     
       
         
         
             
             
         
       
     
     in which formula:  
       E=—CH 2 —; —CH═;                    R, which may be identical or different, represents an alkyl, cycloalkyl, aryl, vinyl, hydrogeno or alkoxy radical,    Z, which may be identical or different, is an organic substituent comprising at least one oxirane, alkenyl ether, oxetane and/or carbonate function, and −a+b=3.    
   
   
       32 . The dental composition as claimed in  claim 31 , in which the silane (G-3) is chosen from the group consisting of the following molecules:  
     
       
         
         
             
             
         
       
     
   
   
       33 . The dental composition as claimed in  claim 1 , in which the compound (G) is an organic compound (G-4) chosen from the group consisting of the molecules:  
     
       
         
         
             
             
         
       
     
     in which formulae: n is an integer between 1 and 10 (limits inclusive);  
     
       
         
         
             
             
         
       
     
     with n<100 and D=linear or branched C 1 -C 12  alkyl; and  
     
       
         
         
             
             
         
       
     
     with n<100 and the group D=linear or branched C 1 -C 12  alkyl.  
   
   
       34 . A process for treating a reinforcing filler, which comprises treating the filler: 
 a) with at least one organosilicon coupling agent (F), and    b) with at least one compound (G),    said organosilicon coupling agent (F) comprising at least one reactive function (rfA) directly linked to a silicon atom reacting with the dental filler, and at least one reactive function (rfB) not directly linked to a silicon atom reacting with a reactive function (rfC) of the compound (G).    
   
   
       35 . The process for treating a reinforcing filler, as claimed in  claim 34 , in which: 
 the reactive function (rfA) directly linked to a silicon atom of the organosilicon coupling agent (F) is an alkoxy or hydroxyl function;    the reactive function (rfB) not directly linked to a silicon atom of the organosilicon coupling agent (F) is an oxirane, oxetane, hydroxyl, acid, carboxylic acid anhydride or diol function; and    the reactive function (rfC) of the compound (G) is an oxirane, oxetane, alkenyl ether or carbonate function.    
   
   
       36 . The process for treating a reinforcing filler as claimed in  claim 34 , comprising the following steps: 
 a) the reinforcing dental filler (B) and at least one organosilicon coupling agent (F) comprising at least one alkoxy and/or hydroxyl function directly linked to a silicon atom and to at least one oxirane, oxetane, hydroxyl and/or diol function, are mixed together in solvent medium,    b) the solvent is evaporated off to obtain an intermediate dental filler (B-1),    c) the intermediate dental filler (B-1) is subjected to a heat treatment so as to allow the coupling reaction between the intermediate dental filler (B-1) and the coupling agent (F) and thus to obtain an intermediate dental filler (B-2),    d) the intermediate dental filler (B-2) is then mixed in solvent medium with at least one compound (G) comprising at least one oxirane, oxetane, alkenyl ether and/or carbonate function,    e) the solvent is evaporated off to obtain an intermediate dental filler (B-3), and    f) the intermediate dental filler (B-3) is subjected to a heat treatment so as to allow the reaction between the intermediate dental filler (B-3) and the compound (G) and thus to obtain a treated dental filler (B-4).    
   
   
       37 . The process for treating a reinforcing filler as claimed in  claim 36 , in which the heat treatment of steps c) and f) of the process (I) is performed by heating to a temperature of less than or equal to 200° C.  
   
   
       38 . The process for treating a reinforcing filler in which an organosilicon coupling agent (F) is used as defined as in  claim 7 .  
   
   
       39 . The process for treating a reinforcing filler in which a compound (G) is used as defined in  claim 10 .  
   
   
       40 . The process for treating a reinforcing filler  claim 34 , in which the reinforcing filler is a mineral glass or a combustion silica.  
   
   
       41 . A reinforcing filler obtained via the process as claimed in  claim 34 .  
   
   
       42 . (canceled)  
   
   
       43 . A dental prosthesis obtained by crosslinking of a composition as claimed in  claim 1 .  
   
   
       44 . Dental restoration material obtained by crosslinking of a composition as claimed in  claim 1.